07 September 2022
Start-up essential: Masterclass EU Lobbying
BlueHealth Innovation Center
"Shaping the policy landscape to empower the digital health sector." Over the last couple of years, investment in European lobbying and public affairs practices have skyrocketed among life sciences companies. The biggest players – the pharmaceutical industry – invested approximately €40 million in 2021 just to influence EU policy. However, they are no longer alone. Find out more during the EU Lobbying Masterclass on the 16th of June with Alicia Rojo Santos, Senior Consultant at Hanover Communications.Registreer je
With the EU increasingly scrutinising a fast-growing digital health industry, three new players have ramped up their efforts: medical devices companies increasingly investing in medical technology and health technology to support their portfolio; big tech diversifying into health and wellbeing; and digital health scaleups realising the importance of the future regulations on their own commercial objectives.
Alicia Rojo Santos
Senior Consultant at Hanover Communications
Ali started her career back in London, initially working on national lobbying in the UK. She is now the client lead for some of Hanover’s largest clients, including Apple in light of its expansion to health and wellbeing.
Masterclass EU Lobbying
Lange Gasthuisstraat 29/31 , 2000 Antwerpen